Radiographically identified necrosis after 90Y microsphere brachytherapy: A new standard for oncologic response assessment?

American Journal of Roentgenology

Volumn 188, Issue 3, 2007, Pages 765-767

  Welsh, James S ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b U S NUCLEAR REGULATORY COMMISSION   (United States)

Author keywords

Abdominal imaging; CT; Interventional radiology; Liver; Oncologic imaging

Indexed keywords

BEVACIZUMAB; FLOXURIDINE; IBRITUMOMAB TIUXETAN; STRONTIUM 90; TOSITUMOMAB I 131; YTTRIUM 90; MCRS1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; YTTRIUM;

BRACHYTHERAPY; HUMAN; LIVER CELL CARCINOMA; NONHODGKIN LYMPHOMA; NOTE; PRIORITY JOURNAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METHODOLOGY; MORTALITY; NECROSIS; RADIOGRAPHY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARD; TREATMENT OUTCOME;

BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; NECROSIS; NUCLEAR PROTEINS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 33847180174     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.5320     Document Type: Note

References (11)

1. Miller FH, Keppke AL, Reddy D, et al. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR 2007; 188:776-783
2. Keppke AL, Salem R, Reddy D, et al. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR 2007; 188:768-775
3. 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004; 60:1552-1563
4. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000; 45:1023-1033
5. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49:1221-1230
6. Picci P, Ferrari S, Bacci G, et al. Treatment recommendations for osteosarcoma and adult soft tissue sarcomas. Drugs 1994; 47:1221-1230
7. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314:1600-1606
8. Bharat A, Brown DB, Crippin JS, et al. Pre-liver transplantation locoregional adjuvant treatment for hepatocellular carcinoma as a strategy to improve long-term survival. J Am Coll Surg 2006; 203:411-420
9. Leung TW, Patt YZ, Lau WY, et al. Complete pathological response is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 1999; 5:1676-1681
10. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985; 56:918-928
11. 90Y microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006; 65:412-425